Results 241 to 250 of about 44,678 (265)
Some of the next articles are maybe not open access.
1980
The superior vena cava (SVC) syndrome is a unique clinical entity first described by William Hunter in 1757. The syndrome develops as a consequence of a pathologic process within the mediastinum and is considered an oncologic emergency because of the acute cerebral syndrome that results from venous obstruction and increased intracerebral pressure.
openaire +2 more sources
The superior vena cava (SVC) syndrome is a unique clinical entity first described by William Hunter in 1757. The syndrome develops as a consequence of a pathologic process within the mediastinum and is considered an oncologic emergency because of the acute cerebral syndrome that results from venous obstruction and increased intracerebral pressure.
openaire +2 more sources
1994
Three years ago, a 71-year-old man had a small cell carcinoma of his parotid managed by superficial parotidectomy and postoperative irradiation (6000 cGy at the 80% isodose line with mixed beam). He now presents with a superior vena cava syndrome. Computed tomography (CT) of the chest with IV contrast showed adlenopathy from the level of C3 to the ...
openaire +2 more sources
Three years ago, a 71-year-old man had a small cell carcinoma of his parotid managed by superficial parotidectomy and postoperative irradiation (6000 cGy at the 80% isodose line with mixed beam). He now presents with a superior vena cava syndrome. Computed tomography (CT) of the chest with IV contrast showed adlenopathy from the level of C3 to the ...
openaire +2 more sources
The Superior Vena Cava Syndrome
2015The superior vena cava syndrome (SVCS) refers to a group of symptoms caused by obstruction or compression of the superior vena cava. Malignant causes represents the majority of all cases of SVCS (bronchogenic carcinoma, lymphoma, metastatic breast carcinoma, primary mediastinal tumors, acute leukemias).
Maria Tolia, George Kyrgias
openaire +2 more sources
1986
The superior vena cava syndrome (SVCS) is a clinical entity first described by William Hunter in 1757 in a patient with saccular aortic aneurysm. The SVCS is due to progressive obstruction of the superior vena cava by extrinsic compression or intrinsic thrombosis.
Prashant K. Rohatgi, Prashant K. Rohatgi
openaire +2 more sources
The superior vena cava syndrome (SVCS) is a clinical entity first described by William Hunter in 1757 in a patient with saccular aortic aneurysm. The SVCS is due to progressive obstruction of the superior vena cava by extrinsic compression or intrinsic thrombosis.
Prashant K. Rohatgi, Prashant K. Rohatgi
openaire +2 more sources
Immunotherapies for hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2021, Florian Castet, Mala K Maini
exaly
Bio-based polymers with performance-advantaged properties
Nature Reviews Materials, 2021Robin M Cywar +2 more
exaly
“Benign” superior vena cava syndrome [PDF]
D.J. Lips +2 more
openaire +2 more sources
Borates: A Rich Source for Optical Materials
Chemical Reviews, 2021Miriding Mutailipu, Kenneth Poeppelmeier
exaly
Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment
Ca-A Cancer Journal for Clinicians, 2011exaly

